The U.S. health department said it ordered about 1.75 million courses of Relenza on March 2 and another 2.2 million courses on March 26.
The department has already ordered 22 million courses of Tamiflu, which until the launch of Relenza was the only drug on the market with the capabilities to prevent influenza A and B and also be used as a treatment for people with the infection.
From CNN.
